Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
Screening for Hepatocellular Carcinoma With Triphasic Helical CT vs. US With Alpha-fetoprotein in Patients With Advanced Liver Disease
Sponsor: Minneapolis Veterans Affairs Medical Center
Listed as NCT01350167, this NA trial focuses on Cirrhosis and End Stage Liver Disease and remains ongoing. Sponsored by Minneapolis Veterans Affairs Medical Center, it has been updated 6 times since 2001, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Minneapolis Veterans Affairs Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .